NO995812L - Metode og sammensetninger for administrering av taxaner oralt til pasienter - Google Patents

Metode og sammensetninger for administrering av taxaner oralt til pasienter

Info

Publication number
NO995812L
NO995812L NO995812A NO995812A NO995812L NO 995812 L NO995812 L NO 995812L NO 995812 A NO995812 A NO 995812A NO 995812 A NO995812 A NO 995812A NO 995812 L NO995812 L NO 995812L
Authority
NO
Norway
Prior art keywords
patients
administration
compositions
taxanes orally
taxanes
Prior art date
Application number
NO995812A
Other languages
English (en)
Other versions
NO995812D0 (no
Inventor
Samuel Broder
Kenneth L Duchin
Sami Selim
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of NO995812D0 publication Critical patent/NO995812D0/no
Publication of NO995812L publication Critical patent/NO995812L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO995812A 1997-05-27 1999-11-26 Metode og sammensetninger for administrering av taxaner oralt til pasienter NO995812L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86351397A 1997-05-27 1997-05-27
PCT/US1998/007776 WO1998053811A1 (en) 1997-05-27 1998-04-22 Method and compositions for administering taxanes orally to human patients

Publications (2)

Publication Number Publication Date
NO995812D0 NO995812D0 (no) 1999-11-26
NO995812L true NO995812L (no) 2000-01-25

Family

ID=25341241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995812A NO995812L (no) 1997-05-27 1999-11-26 Metode og sammensetninger for administrering av taxaner oralt til pasienter

Country Status (23)

Country Link
EP (1) EP0994706B1 (no)
JP (1) JP2002500667A (no)
KR (1) KR100615783B1 (no)
CN (2) CN1261275A (no)
AR (1) AR012731A1 (no)
AT (1) ATE308365T1 (no)
AU (1) AU7130098A (no)
BR (1) BR9809694A (no)
CA (1) CA2290446C (no)
CZ (1) CZ9904244A3 (no)
DE (1) DE69832173T2 (no)
DK (1) DK0994706T3 (no)
ES (1) ES2247690T3 (no)
HK (1) HK1026637A1 (no)
HU (1) HUP0003546A3 (no)
IL (2) IL132992A0 (no)
NO (1) NO995812L (no)
PL (1) PL337064A1 (no)
RU (1) RU2205005C2 (no)
SK (1) SK157599A3 (no)
UA (1) UA74767C2 (no)
WO (1) WO1998053811A1 (no)
ZA (1) ZA984268B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
ATE219363T1 (de) * 1997-06-20 2002-07-15 Baker Norton Pharma Lösliche prodrugs von paclitaxel
GB9718903D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
AU4955200A (en) 1999-05-17 2000-12-05 Cancer Research Ventures Limited A method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs
JP2003512443A (ja) * 1999-10-27 2003-04-02 ベーカー ノートン ファーマシューティカルズ インコーポレイテッド タキサンをヒト患者に経口投与するための方法及び組成物
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
JP2004520398A (ja) * 2001-01-18 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1623706A3 (en) * 2001-02-28 2006-02-22 Bristol-Myers Squibb Company Metronomic dosing of taxanes for inhibiting tumor growth
UY27185A1 (es) * 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
GB0523659D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
CA2763893A1 (en) * 2009-06-02 2010-12-09 Nikan Pharmaceuticals, Llc Antagonism of human formyl peptide receptor for treatment of disease
EP4059497A1 (en) * 2021-03-17 2022-09-21 Dompé farmaceutici S.p.a. C5ar1 inhibitors for treating hypersensitivity reactions to taxanes
JP2024512472A (ja) * 2021-03-17 2024-03-19 ドムペ・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ タキサンに対する過敏性反応を治療するためのc5ar1阻害薬

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
JPH06504772A (ja) * 1990-12-18 1994-06-02 ザ ウエルカム ファウンデーション リミテッド 抗癌剤の薬効を増強し抗多剤耐性を有する薬剤
AU652996B2 (en) * 1991-01-11 1994-09-15 Laboratoires Glaxo S.A. Acridine derivatives
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CZ293076B6 (cs) * 1994-07-26 2004-02-18 Indena S. P. A. Polosyntetické taxany, způsob jejich výroby, farmaceutické prostředky s jejich obsahem a meziprodukty pro jejich výrobu
TW354293B (en) * 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
CA2221444A1 (en) * 1996-01-31 1997-08-07 Steven B. Hansel A method of making pharmaceutically active taxanes orally bioavailable
JP2000512997A (ja) * 1996-06-17 2000-10-03 イーライ・リリー・アンド・カンパニー 薬物耐性および多薬物耐性調節物質
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
KR100661879B1 (ko) * 1998-04-01 2006-12-27 스키에파마 캐나다 인코포레이티드 항암 조성물

Also Published As

Publication number Publication date
CA2290446A1 (en) 1998-12-03
DE69832173T2 (de) 2006-08-03
HK1026637A1 (en) 2000-12-22
WO1998053811A1 (en) 1998-12-03
CZ9904244A3 (cs) 2001-10-17
AR012731A1 (es) 2000-11-08
RU2205005C2 (ru) 2003-05-27
EP0994706B1 (en) 2005-11-02
KR100615783B1 (ko) 2006-08-25
DE69832173D1 (de) 2005-12-08
EP0994706A1 (en) 2000-04-26
CN1550231A (zh) 2004-12-01
KR20010013025A (ko) 2001-02-26
IL132992A (en) 2006-08-20
NO995812D0 (no) 1999-11-26
CN1261275A (zh) 2000-07-26
BR9809694A (pt) 2000-10-03
IL132992A0 (en) 2001-03-19
DK0994706T3 (da) 2006-03-06
UA74767C2 (en) 2006-02-15
ES2247690T3 (es) 2006-03-01
SK157599A3 (en) 2002-10-08
ZA984268B (en) 1999-06-23
PL337064A1 (en) 2000-07-31
AU7130098A (en) 1998-12-30
HUP0003546A3 (en) 2002-12-28
ATE308365T1 (de) 2005-11-15
CA2290446C (en) 2008-01-29
HUP0003546A2 (hu) 2002-11-28
EP0994706A4 (en) 2001-05-16
JP2002500667A (ja) 2002-01-08

Similar Documents

Publication Publication Date Title
DK1079809T3 (da) Enterisk overtrukket farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO995812D0 (no) Metode og sammensetninger for administrering av taxaner oralt til pasienter
IS2058B (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
NO20004741D0 (no) Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode
NO20010260L (no) Tarmbeskyttelsesbelagt farmasøytisk tablett og fremgangsmÕte for fremstilling
IS5097A (is) Fenófíbrat lyfjasamsetning með háa lífeðlisfræðilega upptöku og aðferð til framleiðslu hennar
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
NO20003051D0 (no) Metode for administrering av AspB28-humant insulin
IS5245A (is) Lyfjablanda úr ómeprasól
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
IS5747A (is) Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
PL341230A1 (en) Solid dosage forms of ribavirin for oral administration and method of obtaining them
DK1210119T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
EP1181022A4 (en) MEDICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
EE200200105A (et) Radiofarmatseutilised saadused ja nende valmistamise meetod
NO20022008D0 (no) Fremgangsmåte og preparater for oral administrering av taxaner til humane pasienter
NO991613L (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application